Histone deacetylase inhibitors: a new class of potential therapeutic agents for cancer treatment.
Richon
Victoria M
VM
Aton Pharma, Inc., Tarrytown, New York 10591, USA. vrichon@atonpharma.com
O'Brien
James P
JP
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D047630:Depsipeptides; D004791:Enzyme Inhibitors / Q000627:therapeutic use*; D056572:Histone Deacetylase Inhibitors; D006655:Histone Deacetylases / Q000737:chemistry; D006801:Humans; D009369:Neoplasms / Q000188:drug therapy*; D010456:Peptides, Cyclic
D000900:Anti-Bacterial Agents; D000903:Antibiotics, Antineoplastic; D047630:Depsipeptides; D004791:Enzyme Inhibitors; D056572:Histone Deacetylase Inhibitors; D010456:Peptides, Cyclic; C087123:romidepsin; D006655:Histone Deacetylases